Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DMQE | ISIN: FR0014009ON9 | Ticker-Symbol: N/A
Frankfurt
25.09.23
09:15 Uhr
9,500 Euro
0,000
0,00 %
1-Jahres-Chart  (nicht börsennotiert)
EUREKING SA Chart 1 Jahr

Aktuelle News zur EUREKING

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
06.12.23XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 06.12.2023766The following instruments on Boerse Frankfurt do have their last trading day on 06.12.2023Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 06.12.2023ISIN NameCA03078N1006 AMERIWEST...
► Artikel lesen
28.11.23XFRA C10: AUSSETZUNG/SUSPENSION311DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILEUREKING PFD B EO...
► Artikel lesen
24.11.23eureKING: Delisting of all financial instruments issued by the Company following the extraordinary general meeting of November 28, 2023300Paris, France, November 24, 2023 - eureKING (ISIN: FR0014009ON9, Euronext Paris, the "Company"), the first European special purpose acquisition company ("SPAC") in healthcare dedicated to bioproduction...
► Artikel lesen
12.10.23eureKING will not complete its Proposed acquisitions of Skyepharma and SCTbio and will launch its dissolution and liquidation proceeding285Paris, France, October 12 , 2023 - eureKING (ISIN: FR0014009ON9, Euronext Paris), the first European special purpose acquisition company ("SPAC") in healthcare dedicated to bioproduction, announces...
► Artikel lesen
30.05.23eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces the signature of a put option for the potential acquisition of Skyepharma to build a new European bio-CDMO leader824Skyepharma is a France-based CDMO with over 20 years of innovation and development expertise and a renowned player in the global biopharma and consumer health industries. The company's unique offer...
► Artikel lesen
16.05.23eureKING, the first European SPAC in healthcare dedicated to biomanufacturing, announces its intention to combine with Skyepharma to build a new European bio-CDMO leader499Skyepharma, a France-based CDMO with over 20 years of innovation and development expertise, is a renowned player in the global biopharma and consumer health industries. The company's unique...
► Artikel lesen
6 Nachrichten in den letzten 12 Monaten